BCL2L1 and gastric cancer: A recent study showed that the overexpressed FAS induced anoikis resistance in gastric cancer via the p-ERK1/2/Bcl-xL pathway, whereas the silencing of FAS reversed anoikis resistance and retarded the migration and invasion of gastric cancer cells (Yu et al., 2021).